Ignite Creation Date:
2024-05-05 @ 6:54 PM
Last Modification Date:
2024-10-26 @ 9:38 AM
Study NCT ID:
NCT00562640
Status:
COMPLETED
Last Update Posted:
2023-09-15
First Post:
2007-11-21
Brief Title:
Autologous T Cells With or Without Cyclophosphamide and Fludarabine in Treating Patients With Recurrent or Persistent Advanced Ovarian Epithelial Cancer Primary Peritoneal Cavity Cancer or Fallopian Tube Cancer Fludarabine Treatment Closed as of 12012009
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Memorial Sloan Kettering Cancer Center
Organization Data
Organization:
Memorial Sloan Kettering Cancer Center
Class:
OTHER
Study ID:
06-155
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |